Clinical Trial Update: Exenatide and Metformin Therapy in Overweight Women With PCOS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of exenatide and metformin in overweight women with polycystic ovary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• EXENATIDE (EXENATIDE)
• metformin (metformin)

Snippet

Sponsor: Metabolic Center of Louisiana Research Foundation | Conditions: Polycystic Ovary Syndrome | Phase 2 | Status: COMPLETED